These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 17478956)
21. Hepatitis D virus infection among hepatitis B virus surface antigen positive individuals in Upper Egypt: Prevalence and clinical features. Makhlouf NA; Morsy KH; Mahmoud AA J Infect Public Health; 2019; 12(3):350-356. PubMed ID: 30833193 [TBL] [Abstract][Full Text] [Related]
22. The global prevalence of hepatitis D virus infection: Systematic review and meta-analysis. Stockdale AJ; Kreuels B; Henrion MYR; Giorgi E; Kyomuhangi I; de Martel C; Hutin Y; Geretti AM J Hepatol; 2020 Sep; 73(3):523-532. PubMed ID: 32335166 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596 [TBL] [Abstract][Full Text] [Related]
24. An overview of triple infection with hepatitis B, C and D viruses. Riaz M; Idrees M; Kanwal H; Kabir F Virol J; 2011 Jul; 8():368. PubMed ID: 21791115 [TBL] [Abstract][Full Text] [Related]
25. HDV seroprevalence in HBsAg positive patients. Abbasi A; Bhutto AR; Butt N; Mahmood K J Coll Physicians Surg Pak; 2014 Sep; 24(9):624-7. PubMed ID: 25233963 [TBL] [Abstract][Full Text] [Related]
26. Epidemiology of blood-borne viral infections in Afghanistan. Husseini AA; Saeed KMI; Yurdcu E; Sertoz R; Bozdayi AM Arch Virol; 2019 Aug; 164(8):2083-2090. PubMed ID: 31134354 [TBL] [Abstract][Full Text] [Related]
27. Hepatitis B, C, and D virus infection showing distinct patterns between injection drug users and the general population. Chen F; Zhang J; Guo F; Wen B; Luo S; Yuan D; Lin Y; Ou W; Tang P; Dai G; Li F; Liu W; Qu X J Gastroenterol Hepatol; 2017 Feb; 32(2):515-520. PubMed ID: 27248508 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis B and Delta virus are prevalent but often subclinical co-infections among HIV infected patients in Guinea-Bissau, West Africa: a cross-sectional study. Hønge BL; Jespersen S; Medina C; Té Dda S; da Silva ZJ; Lewin S; Østergaard L; Erikstrup C; Wejse C; Laursen AL; Krarup H; PLoS One; 2014; 9(6):e99971. PubMed ID: 24915064 [TBL] [Abstract][Full Text] [Related]
30. Molecular epidemiology of Hepatitis B virus, Hepatitis C virus, and Hepatitis D virus in general population of Afghanistan. Husseini AA; Islam Saeed KM; Yurdcu E; Bozdayı AM Turk J Gastroenterol; 2020 Sep; 31(9):658-666. PubMed ID: 33090103 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis B, C, and D virus infections in patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma: a comparative study in Niger. Cenac A; Pedroso ML; Djibo A; Develoux M; Pichoud C; Lamothe F; Trepo C; Warter A Am J Trop Med Hyg; 1995 Apr; 52(4):293-6. PubMed ID: 7537942 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of hepatitis delta virus infection among hepatitis B virus surface antigen positive patients circulating in the largest province of Pakistan. Zaidi G; Idrees M; Malik FA; Amin I; Shahid M; Younas S; Hussain R; Awan Z; Tariq A; Parveen K Virol J; 2010 Oct; 7():283. PubMed ID: 20977704 [TBL] [Abstract][Full Text] [Related]
33. Virological and clinical characteristics of delta hepatitis in Central Europe. Heidrich B; Deterding K; Tillmann HL; Raupach R; Manns MP; Wedemeyer H J Viral Hepat; 2009 Dec; 16(12):883-94. PubMed ID: 19566789 [TBL] [Abstract][Full Text] [Related]
34. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981 [TBL] [Abstract][Full Text] [Related]
35. Characterization of hepatitis B and delta coinfection in Israel. Shirazi R; Ram D; Rakovsky A; Bucris E; Gozlan Y; Lustig Y; Shaked-Mishan P; Picard O; Shemer-Avni Y; Ben-Zvi H; Halutz O; Lurie Y; Veizman E; Carlebach M; Braun M; Naftaly MC; Shlomai A; Safadi R; Mendelson E; Sklan EH; Ben-Ari Z; Mor O BMC Infect Dis; 2018 Feb; 18(1):97. PubMed ID: 29486716 [TBL] [Abstract][Full Text] [Related]
36. Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon. Ndzie Ondigui JL; Mafopa Goumkwa N; Lobe C; Wandji B; Awoumou P; Voussou Djivida P; Peyonga P; Manju Atah S; Verbe V; Kamgaing Simo R; Moudourou SA; Gutierrez A; Garcia R; Fernandez I; Riwom Essama SH; Mbu R; Torimiro J PLoS One; 2024; 19(6):e0287491. PubMed ID: 38900729 [TBL] [Abstract][Full Text] [Related]
37. Seroepidemiology and clinical features of hepatitis delta among HBsAg carriers: a study from Hepatitis Clinic of Iranian Blood Transfusion Organization. Keshvari M; Alavian SM; Aghaee B; Behnava B; Mahdavi M; Fesharaki MG; Sharafi H Transfus Med; 2014 Dec; 24(6):411-7. PubMed ID: 25523297 [TBL] [Abstract][Full Text] [Related]
38. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus]. de Miguel J; Collazos J; Mayo J; López de Goicoechea MJ; Echániz C; Mendarte U Rev Clin Esp; 1994 Oct; 194(10):897-900. PubMed ID: 7800870 [TBL] [Abstract][Full Text] [Related]
39. Epidemiology of hepatitis B, C and D in Malawi: systematic review. Stockdale AJ; Mitambo C; Everett D; Geretti AM; Gordon MA BMC Infect Dis; 2018 Oct; 18(1):516. PubMed ID: 30314448 [TBL] [Abstract][Full Text] [Related]
40. Prevalence and associated risk factors for hepatitis B and C viruses among refugee populations living in Mahama, Rwanda: A cross-sectional study. Kamali I; Barnhart DA; Ndahimana JD; Noor K; Mumporeze J; Nyirahabihirwe F; Gakuru JP; Musafiri T; Urusaro S; Makuza JD; Serumondo J; Rwamuhinda DD; Nkundibiza M; Kateera F; Nshogoza GR; Mubiligi JM PLoS One; 2021; 16(10):e0257917. PubMed ID: 34634039 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]